Arkolith/Insider Trading/PLRX/Form 4

Cummings Keith Lamont

Chief Financial OfficerPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Jan 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$169K
Net Open-Market Flow
-$169K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 17, 2024Sell(S)10K$17.23$169K195K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746473-24-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML